Top 4 NASDAQ Stocks In The Drug Delivery Industry With The Highest Revenue

Below are the drug delivery stocks on the NASDAQ in terms of revenue. The trailing-twelve-month revenue at Alkermes plc

is $577.21 million. Alkermes' profit margin for the same period is 4.08%. The trailing-twelve-month revenue at PetMed Express

is $235.88 million. PetMed Express' EPS for the same period is $0.90. The trailing-twelve-month revenue at Columbia Laboratories

is $28.93 million. Columbia Laboratories' ROE for the same period is 16.90%. The trailing-twelve-month revenue at Flamel Technologies SA

is $22.44 million. Flamel Technologies' gross profit for the same period is $20.24 million.